• 1. Enantiomeric helical TiO2 nanofibers modulate different peptide assemblies and subsequent cellular behaviors?
  Xu Jie,Deng Xu,Weili Wei RSC Adv., 2019,9, 29149-29153
• 2. Emerging investigator series: kinetics of diopside reactivity for carbon mineralization in mafic–ultramafic rocks
  BrianaAguila,LandonHardee,H.ToddSchaef,SiavashZare,MohammadJavadAbdolhosseiniQomi,JarrodV.Crum,JadeE.HollimanJr.,ElenaTajueloRodriguez,LawrenceM.Anovitz,KevinM.Rosso,QuinR.S.Miller
• 3. Evolved polymerases facilitate selection of fully 2′-OMe-modified aptamers?
  Zhixia Liu,Tingjian Chen,Floyd E. Romesberg Chem. Sci., 2017,8, 8179-8182
• 4. Estimation of hydrogen sulfide from crude petroleum: a unique invention using a simple chemosensor?
  Shampa Kundu,Prithidipa Sahoo New J. Chem., 2019,43, 12369-12374
• 5. Enantiomorphic symmetry breaking in crystallization of molten sodium chlorate?
  Martin R. Ward,Gary W. Copeland,Andrew J. Alexander Chem. Commun., 2010,46, 7634-7636

Comprehensive Guide to Pamoic Acid Disodium (CAS No. 6640-22-8): Properties, Applications, and Market Insights

Pamoic acid disodium (CAS No. 6640-22-8) is a specialized chemical compound widely recognized in pharmaceutical and research industries. This sodium salt of pamoic acid is valued for its unique chemical properties, making it a critical component in drug formulation and analytical chemistry. With the increasing demand for pharmaceutical intermediates and analytical reagents, understanding the role of pamoic acid disodium salt has become essential for professionals in these fields.

The chemical structure of pamoic acid disodium features a disodium salt form of pamoic acid, which enhances its solubility and stability in aqueous solutions. This property is particularly beneficial in drug delivery systems, where controlled release and bioavailability are paramount. Researchers often utilize 6640-22-8 as a counterion in the formulation of poorly soluble drugs, improving their therapeutic efficacy. The compound's ability to form stable complexes with active pharmaceutical ingredients (APIs) has made it a popular choice in pharmaceutical manufacturing.

One of the most common applications of pamoic acid disodium is in the preparation of long-acting injectable formulations. Its use in sustained-release drug products ensures a gradual release of the active ingredient, reducing dosing frequency and improving patient compliance. This application aligns with the growing trend toward personalized medicine and patient-centric drug development, topics that are currently dominating discussions in the pharmaceutical industry.

In addition to its pharmaceutical uses, pamoic acid disodium is also employed in analytical chemistry as a chelating agent and precipitating reagent. Its ability to form insoluble complexes with certain metal ions makes it valuable in qualitative and quantitative analysis. Laboratories frequently use CAS 6640-22-8 for the isolation and purification of specific compounds, highlighting its versatility beyond drug formulation.

The market for pamoic acid disodium salt is experiencing steady growth, driven by advancements in drug delivery technologies and increasing R&D investments in the pharmaceutical sector. Companies specializing in fine chemicals and pharmaceutical excipients are actively expanding their product portfolios to include high-purity grades of pamoic acid disodium, catering to the stringent requirements of regulatory agencies.

Quality control is a critical aspect of pamoic acid disodium production, with manufacturers adhering to strict guidelines such as Good Manufacturing Practices (GMP) and International Council for Harmonisation (ICH) standards. The compound is typically supplied as a white to off-white powder, with specifications including assay purity, residual solvent levels, and heavy metal content. These parameters ensure its suitability for use in sensitive applications like injectable formulations and diagnostic reagents.

Recent innovations in green chemistry have also influenced the production processes of pamoic acid disodium. Manufacturers are exploring eco-friendly synthesis routes and sustainable sourcing of raw materials to reduce environmental impact. This shift resonates with the global push toward sustainable pharmaceutical practices, a topic gaining traction among environmentally conscious consumers and regulatory bodies alike.

For researchers and procurement specialists seeking reliable sources of pamoic acid disodium, it is crucial to partner with reputable suppliers who provide comprehensive technical data and regulatory documentation. Certificates of Analysis (CoA), Material Safety Data Sheets (MSDS), and Drug Master Files (DMF) are essential for verifying the quality and compliance of CAS 6640-22-8 products.

In conclusion, pamoic acid disodium (CAS No. 6640-22-8) plays a pivotal role in modern pharmaceutical and analytical applications. Its unique properties as a drug formulation aid and analytical reagent continue to drive demand across multiple industries. As the focus on advanced drug delivery systems and sustainable chemistry intensifies, the importance of this versatile compound is expected to grow further in the coming years.

• 122-25-8(5,5'-Methylenebis(2-hydroxybenzoic Acid) (~90%))
• 130-85-8(Pamoic Acid)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)